Case number 1:21-cv-01553
Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 14, 2023 | 33 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Stipulation of Dismissal)(mdb) (Entered: 11/14/2023) (0) |
| Nov 13, 2023 | 32 | SO ORDERED re (25 in 1:22-cv-00439-MN, 19 in 1:23-cv-00266-MN, 31 in 1:21-cv-01553-MN, 19 in 1:22-cv-01291-MN, 35 in 1:21-cv-01118-MN, 278 in 1:21-cv-01042-MN) Stipulated Dismissal ***Civil Case Terminated. Signed by Judge Maryellen Noreika on 11/13/2023. (dlw) (Entered: 11/13/2023) (2) |
| Nov 10, 2023 | 31 | STIPULATION of Dismissal by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Phillips, John) (Entered: 11/10/2023) (2) |
| Jun 13, 2022 | 30 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Jennifer M. Coronel as co-counsel. Reason for request: No longer affiliated with Locke Lord LLP. (Bilson, David) |
| Apr 19, 2022 | 29 | Scheduling Order (21) Docket Text: SCHEDULING ORDER: These matters are consolidated for all purposes and all filing shall be made in the lead action, C.A. No. 21-1042 (MN), only. Joinder of Parties due by 1/13/2023. Amended Pleadings due by 1/13/2023. Fact Discovery completed by 1/20/2023. Opening Expert Reports due by 7/17/2023. Rebuttal Expert Reports due by 8/28/2023. Reply Expert Reports due by 9/25/2023. Expert Discovery due by 11/3/2023. Claim Construction Opening Brief served by 3/23/2023. Claim Construction Answering Brief served by 4/20/2023. Claim Construction Reply Brief served by 5/10/2023. Claim Construction Surreply Brief served by 5/26/2023. Joint Claim Construction Brief filed by 6/2/2023. A Markman Hearing is set for 6/23/2023 at 11:00 AM in Courtroom 4A before Judge Maryellen Noreika. A Pretrial Conference is set for 12/18/2023 at 04:30 PM in Courtroom 4A before Judge Maryellen Noreika. A 9-day Bench Trial is set for 1/2/2024 at 08:30 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 4/19/2022. (dlw) |
| Apr 19, 2022 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:21-cv-01042-MN. (dlw) |
| Apr 13, 2022 | 28 | Proposed Order (21) Docket Text: PROPOSED ORDER // Scheduling Order by Neurocrine Biosciences, Inc. (Balick, Steven) Modified on 4/14/2022 (dlw). |
| Apr 13, 2022 | 27 | Letter (1) Docket Text: Letter to The Honorable Maryellen Noreika from Steven J. Balick regarding the Parties' Jointly Proposed Scheduling Order. (Balick, Steven) |
| Apr 12, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re (25 in 1:21-cv-01148-MN, 19 in 1:21-cv-01067-MN, 27 in 1:21-cv-01043-MN, 16 in 1:21-cv-01408-MN, 19 in 1:21-cv-01042-MN, 26 in 1:21-cv-01553-MN, 30 in 1:21-cv-01118-MN, 18 in 1:21-cv-01464-MN, 17 in 1:22-cv-00092-MN) Stipulation Extending Time to File Revised Proposed Scheduling Order to 4/13/2022. ORDERED by Judge Maryellen Noreika on 4/12/2022. (dlw) |
| Apr 11, 2022 | 26 | Stipulation (5) Docket Text: STIPULATION Seeking to Extend the Deadline for Submission of a Revised Proposed Scheduling Order, by Neurocrine Biosciences, Inc.. (Balick, Steven) |
| Apr 5, 2022 | 25 | Transcript (20) Docket Text: Official Transcript of Teleconference held on 04/04/2022 before Judge Maryellen Noreika. Court Reporter/Transcriber Dale C. Hawkins,Email: Dale_Hawkins@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 4/26/2022. Redacted Transcript Deadline set for 5/6/2022. Release of Transcript Restriction set for 7/5/2022. (dh) |
| Apr 4, 2022 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Maryellen Noreika - Scheduling Telephone Conference held on 4/4/2022. Discussion regarding the proposed schedule and disputes raised in the parties' proposal. A Markman Hearing is set for 6/23/2023, the Pretrial Conference will be set in December 2023 once the revised proposed schedule is filed, and a 9-day Bench Trial is set for 1/2/2024. The defendants are limited to three motions in limine collectively; if they wish to file more than three, they must submit a letter requesting such closer to trial. The revised proposed scheduling order is due by the end of the day on 4/11/2022. (Court Reporter Dale Hawkins.) Associated Cases: 1:21-cv-01042-MN et al.(mdb) |
| Mar 25, 2022 | N/A | Order Setting Scheduling Conference (0) Docket Text: ORAL ORDER Setting Telephonic Scheduling Conference: IT IS HEREBY ORDERED that a telephonic Scheduling Conference is set for 4/4/2022 at 11:00 AM before Judge Maryellen Noreika. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 3/25/2022. (dlw) |
| Mar 24, 2022 | 23 | Text of Proposed Order (23) |
| Mar 24, 2022 | 23 | Main Document (1) Docket Text: Letter to The Honorable Maryellen Noreika from Andrew C. Mayo regarding proposed scheduling order. (Attachments: # (1) Text of Proposed Order)(Mayo, Andrew) |
| Mar 24, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Timothy F. Peterson for Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Mar 23, 2022 | 22 | Certification of Leah M. Brackensick (1) |
| Mar 23, 2022 | 22 | Certification of Jennifer M. Coronel (1) |
| Mar 23, 2022 | 22 | Certification of Timothy F. Peterson (1) |
| Mar 23, 2022 | 22 | Certification of Michael J. Gaertner (1) |
| Mar 23, 2022 | 22 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, Timothy F. Peterson, Jennifer M. Coronel and Leah M. Brackensick - filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Attachments: # (1) Certification of Michael J. Gaertner, # (2) Certification of Timothy F. Peterson, # (3) Certification of Jennifer M. Coronel, # (4) Certification of Leah M. Brackensick)(Bilson, David) |
| Mar 23, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Michael J. Gaertner, Jennifer M. Coronel, and Leah M. Brackensick for Zydus Pharmaceuticals (USA) Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Mar 23, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [22] MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, Timothy F. Peterson, Jennifer M. Coronel and Leah M. Brackensick filed by Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Limited. ORDERED by Judge Maryellen Noreika on 3/23/2022. (dlw) |
| Mar 21, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re (19 in 1:21-cv-01148-MN, 15 in 1:21-cv-01067-MN, 21 in 1:21-cv-01043-MN, 14 in 1:21-cv-01464-MN, 26 in 1:21-cv-01118-MN, 12 in 1:21-cv-01408-MN, 15 in 1:21-cv-01042-MN, 21 in 1:21-cv-01553-MN, 8 in 1:22-cv-00092-MN) Stipulation to Extend Time to submit proposed scheduling order - IT IS HEREBY ORDERED that the deadline to submit the proposal scheduling order is extended through and including 3/24/2022. ORDERED by Judge Maryellen Noreika on 3/21/2022. (dlw) |
| Mar 18, 2022 | 19 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Zydus Lifesciences Limited for Zydus Worldwide DMCC filed by Zydus Worldwide DMCC. (Bilson, David) |
| Mar 18, 2022 | 20 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Cadila Healthcare Limited. (Bilson, David) |
| Mar 18, 2022 | 21 | Stipulation (5) Docket Text: STIPULATION Seeking to Extend the Deadline by which a Proposed Scheduling Order is Due, by Neurocrine Biosciences, Inc.. (Balick, Steven) |
| Mar 18, 2022 | 18 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Zydus Lifesciences Limited for Zydus Pharmaceuticals (USA) Inc. filed by Zydus Pharmaceuticals (USA) Inc.. (Bilson, David) |
| Mar 18, 2022 | 17 | Answer to Complaint (26) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) Modified on 3/18/2022 (dlw). |
| Mar 10, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re (16 in 1:21-cv-01553-MN, 14 in 1:21-cv-01067-MN, 18 in 1:21-cv-01148-MN, 25 in 1:21-cv-01118-MN, 13 in 1:21-cv-01464-MN, 7 in 1:22-cv-00092-MN, 14 in 1:21-cv-01042-MN, 20 in 1:21-cv-01043-MN, 11 in 1:21-cv-01408-MN) Stipulation to Extend Time to submit a proposed scheduling order through and including 3/18/2022. ORDERED by Judge Maryellen Noreika on 3/10/2022. (dlw) |
| Mar 9, 2022 | 16 | Stipulation (5) Docket Text: STIPULATION Seeking to Extend the Deadline by which a Proposed Scheduling Order is Due, by Neurocrine Biosciences, Inc.. (Balick, Steven) |
| Feb 15, 2022 | 15 | Redacted Document (5) Docket Text: REDACTED VERSION of (14 in 1:21-cv-01118-MN, 12 in 1:21-cv-01553-MN) Stipulation by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Phillips, John) |
| Feb 9, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER - IT IS HEREBY ORDERED that, within thirty (30) days from the date of this Order, the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposed order, which is also consistent with the following guidance. The parties shall provide final contentions (i.e., final infringement and invalidity contentions, as well as final non-infringement and validity contentions) around the time that fact discovery closes (i.e., several weeks prior to or after the deadline to complete fact discovery) and at least three weeks before Plaintiff serves its opening claim construction brief. Final contentions shall include a party's contentions under its proposed construction(s), as well as under the opposing construction(s) (if such an alternative contention exists). As such, the parties are encouraged to exchange proposed claim terms and proposed constructions early in the case but in no event later than necessary to allow the parties to include alternative contentions in their final contentions. The joint claim construction chart shall be due one week after the parties have completed their exchange of final contentions, and the joint claim construction brief must be filed at least three weeks before the claim construction hearing. The parties shall leave at least three weeks between the claim construction hearing and the opening of expert discovery. The parties are to use the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Noreika, Forms), and the parties must include a proposal for the length and timing of trial. If there are disputes or issues that the Court needs to address in the proposed scheduling order, the parties shall direct the Court to the paragraph numbers in which those appear in a cover letter to the Court. ORDERED by Judge Maryellen Noreika on 2/9/2022. (dlw) |
| Jan 27, 2022 | 11 | Affidavit of Service (2) Docket Text: AFFIDAVIT of Service for Summons, Complaint, and related documents served on Zydus Healthcare (USA) LLC on January 25, 2022, filed by Neurocrine Biosciences, Inc.. (Mayo, Andrew) |
| Jan 25, 2022 | 10 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Neurocrine Biosciences, Inc.: For Cadila Healthcare Limited waiver sent on 1/17/2022, answer due 4/18/2022. (Balick, Steven) |
| Jan 25, 2022 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Neurocrine Biosciences, Inc.: For Zydus Worldwide DMCC waiver sent on 1/17/2022, answer due 4/18/2022. (Balick, Steven) |
| Jan 25, 2022 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Neurocrine Biosciences, Inc.: For Zydus Pharmaceuticals (USA) Inc. waiver sent on 1/17/2022, answer due 3/18/2022. (Balick, Steven) |
| Jan 20, 2022 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: At the request of counsel, D.I. 6 and the corresponding SO ORDERED have been deleted from the docket. (dlw) |
| Jan 7, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Lauren J. Dowty, James B. Monroe, Jeanette M. Roorda, and Erin M. Sommers for Neurocrine Biosciences, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (Associated Cases: 1:21-cv-01067-MN, 1:21-cv-01042-MN, 1:21-cv-01148-MN, 1:21-cv-01043-MN, 1:21-cv-01118-MN, 1:21-cv-01408-MN, 1:21-cv-01553-MN, 1:21-cv-01464-MN)(srs) |
| Jan 4, 2022 | 7 | Motion for Leave to Appear Pro Hac Vice (11) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Erin M. Sommers, Lauren J. Dowty, and Jeanette M. Roorda - filed by Neurocrine Biosciences, Inc.. (Mayo, Andrew) |
| Jan 4, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re (12 in 1:21-cv-01067-MN, 12 in 1:21-cv-01042-MN, 12 in 1:21-cv-01148-MN, 11 in 1:21-cv-01043-MN, 9 in 1:21-cv-01118-MN, 9 in 1:21-cv-01408-MN, 7 in 1:21-cv-01553-MN, 11 in 1:21-cv-01464-MN) MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Erin M. Sommers, Lauren J. Dowty, and Jeanette M. Roorda filed by Neurocrine Biosciences, Inc. ORDERED by Judge Maryellen Noreika on 1/4/2022. (dlw) |
| Dec 21, 2021 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Cadila Healthcare Limited on 12/21/2021. (smg) |
| Nov 3, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (nms) |
| Oct 29, 2021 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Neurocrine Biosciences, Inc. (apk) |
| Oct 29, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,993,941 ;11,026,931 ;11,026,939 ;11,040,029. (apk) |
| Oct 29, 2021 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/17/2021. Date of Expiration of Patent: SEE ANDA FORM.Thirty Month Stay Deadline: 10/11/2024. (apk) |
| Oct 29, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
| Oct 29, 2021 | 1 | Civil Cover Sheet (3) |
| Oct 29, 2021 | 1 | Complaint* (1) |
| Oct 29, 2021 | 1 | Exhibit A-D (112) |
| Oct 29, 2021 | 1 | Main Document (24) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Cadila Healthcare Limited, Zydus Healthcare (USA) LLC, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3733135.) - filed by Neurocrine Biosciences, Inc.. (Attachments: # (1) Exhibit A-D, # (2) Civil Cover Sheet)(apk) |
| Oct 29, 2021 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (apk) |
